These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
346 related articles for article (PubMed ID: 16400351)
1. Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis. Preda CM; Vermeire S; Rutgeerts P; Joosens S; Diculescu M; Marica C; Ciocarlan M; Mirea V; Oproiu A Rom J Gastroenterol; 2005 Dec; 14(4):357-60. PubMed ID: 16400351 [TBL] [Abstract][Full Text] [Related]
2. [Significance of the determination of antineutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis and Crohn's disease]. García-Herola A; Nos P; Hoyos M; Hinojosa J; Molés JR; Pascual S; Bustamante M; Sánchez Cuenca JM; Carmona E; Ponce J; Berenguer J Gastroenterol Hepatol; 1998 Apr; 21(4):169-73. PubMed ID: 9633176 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and diagnostic role of antineutrophil cytoplasmic antibodies in inflammatory bowel disease. Bansi DS; Chapman RW; Fleming KA Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):881-5. PubMed ID: 8889455 [TBL] [Abstract][Full Text] [Related]
4. Antineutrophil cytoplasmic antibodies in Japanese patients with inflammatory bowel disease: prevalence and recognition of putative antigens. Sugi K; Saitoh O; Matsuse R; Tabata K; Uchida K; Kojima K; Nakagawa K; Tanaka S; Teranishi T; Hirata I; Katsu K Am J Gastroenterol; 1999 May; 94(5):1304-12. PubMed ID: 10235211 [TBL] [Abstract][Full Text] [Related]
5. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania. Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689 [TBL] [Abstract][Full Text] [Related]
6. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689 [TBL] [Abstract][Full Text] [Related]
7. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype. Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007 [TBL] [Abstract][Full Text] [Related]
8. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases]. Mokrowiecka A; Gasiorowska A; Małecka-Panas E Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341 [TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role. Kull K; Salupere R; Uibo R; Ots M; Salupere V Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542 [TBL] [Abstract][Full Text] [Related]
11. Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype. Seow CH; Stempak JM; Xu W; Lan H; Griffiths AM; Greenberg GR; Steinhart AH; Dotan N; Silverberg MS Am J Gastroenterol; 2009 Jun; 104(6):1426-34. PubMed ID: 19491856 [TBL] [Abstract][Full Text] [Related]
12. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China. Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669 [TBL] [Abstract][Full Text] [Related]
13. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases. Bartůnková J; Kolárová I; Sedivá A; Hölzelová E Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458 [TBL] [Abstract][Full Text] [Related]
14. [Interest of serologic markers in inflammatory bowel disease. About 105 cases]. Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802 [TBL] [Abstract][Full Text] [Related]
15. Relationship between ANCA and clinical activity in inflammatory bowel disease: variation in prevalence of ANCA and evidence of heterogeneity. Abad E; Tural C; Mirapeix E; Cuxart A J Autoimmun; 1997 Apr; 10(2):175-80. PubMed ID: 9185879 [TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease. Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652 [TBL] [Abstract][Full Text] [Related]
17. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease. Mokrowiecka A; Gasiorowska A; Malecka-Panas E Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273 [TBL] [Abstract][Full Text] [Related]
18. PR3-ANCA: a promising biomarker for ulcerative colitis with extensive disease. Mahler M; Bogdanos DP; Pavlidis P; Fritzler MJ; Csernok E; Damoiseaux J; Bentow C; Shums Z; Forbes A; Norman GL Clin Chim Acta; 2013 Sep; 424():267-73. PubMed ID: 23806819 [TBL] [Abstract][Full Text] [Related]
19. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease]. Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913 [TBL] [Abstract][Full Text] [Related]
20. Perinuclear anti-neutrophil cytoplasmic antibodies are spontaneously produced by mucosal B cells of ulcerative colitis patients. Targan SR; Landers CJ; Cobb L; MacDermott RP; Vidrich A J Immunol; 1995 Sep; 155(6):3262-7. PubMed ID: 7673739 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]